Dendrimer-based posaconazole nanoplatform for antifungal therapy

We examined formulating a new antifungal agent, posaconazole (POS) and its derivatives, with different molecular vehicles. Several combinations of drug and carrier molecules were synthesized, and their antifungal activities were evaluated against Aspergillus fumigatus. Posaconazole and four of its d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Shengzhuang, Chen, Jesse, Cannon, Jayme, Cao, Zhengyi, Baker, James R., Wang, Su He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510609/
https://www.ncbi.nlm.nih.gov/pubmed/34617850
http://dx.doi.org/10.1080/10717544.2021.1986605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510609/
https://www.ncbi.nlm.nih.gov/pubmed/34617850
http://dx.doi.org/10.1080/10717544.2021.1986605

Ejemplares similares